CEB-01 in Paediatrics With Locally Resectable Abdominal Tumours

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Locally Resectable Paediatric Tumours
Interventions
PROCEDURE

Standard surgery

The location and size of the tumor determine the type of surgery.

DRUG

CEB-01

It is novel formulation for local release of chemotherapy. It consists of a biocompatible and biodegradable nanofiber membrane made of poly(lactic-co-glycolic acid) (PLGA), which is loaded with the anti-tumor drug SN-38 and implanted in the surgical bed after tumor removal.

Trial Locations (1)

08950

RECRUITING

Hospital Sant Joan de Déu, Esplugues de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CEBIOTEX

INDUSTRY